OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
TNH59

TNH Hospital Group JSC

Healthcare Facilities & ServicesVerified

TNH Hospital Group JSC has a debt-to-equity ratio of 0.61, indicating a moderate level of leverage, and a current ratio of 0.9, suggesting potential liquidity constraints. The company's return on equity is -0.0545 and return on assets is -0.0324, both of which are negative, indicating poor profitability and asset utilization. The company's operating income is -90,147,690,770.0 VND, and net income is -93,131,476,740.0 VND, both of which are negative, indicating a significant loss-making position. This is far below the industry's preferred metrics for profitability and returns, which typically require positive returns and stable operating margins. TNH Hospital Group JSC operates in a single segment, with all revenue derived from hospital services in Vietnam. There is no geographic diversification, and the company's revenue is entirely concentrated in its domestic operations. The company's revenue is 509,536,456,610.0 VND, but with a negative operating cash flow of -47,910,474,880.0 VND and a free cash flow of -389,891,146,050.0 VND, it is evident that the company is not generating sufficient cash to sustain operations or fund growth. The capital expenditure of -369,213,145,110.0 VND indicates significant investment in infrastructure, but this has not translated into positive cash flow. The company faces medium liquidity risk and low dilution risk, but the key flag of negative net cash after subtracting total debt is a significant concern. The company has not issued new shares recently, and there is no indication of dilution pressure in the near term. Recent filings and transcripts do not provide additional insights into the company's operations or strategic direction. The company's financial performance remains a concern, with no clear path to profitability or improved cash flow.

30-day price · TNH-170.00 (-1.7%)
Low$9950.00High$10650.00Close$9980.00As of17 May, 00:00 UTC
Profile
CompanyTNH Hospital Group JSC
TickerTNH.HM
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. TNH Hospital Group JSC operates as a Vietnam-based hospital services provider, managing and operating Thai Nguyen International Hospital and Yen Binh Thai Nguyen General Hospital, offering a wide range of medical and surgical services.

Classification. TNH Hospital Group JSC is classified under the Healthcare sector, specifically in the Healthcare Facilities & Services industry, with a classification confidence of 0.92.

TNH Hospital Group JSC has a debt-to-equity ratio of 0.61, indicating a moderate level of leverage, and a current ratio of 0.9, suggesting potential liquidity constraints. The company's return on equity is -0.0545 and return on assets is -0.0324, both of which are negative, indicating poor profitability and asset utilization. The company's operating income is -90,147,690,770.0 VND, and net income is -93,131,476,740.0 VND, both of which are negative, indicating a significant loss-making position. This is far below the industry's preferred metrics for profitability and returns, which typically require positive returns and stable operating margins. TNH Hospital Group JSC operates in a single segment, with all revenue derived from hospital services in Vietnam. There is no geographic diversification, and the company's revenue is entirely concentrated in its domestic operations. The company's revenue is 509,536,456,610.0 VND, but with a negative operating cash flow of -47,910,474,880.0 VND and a free cash flow of -389,891,146,050.0 VND, it is evident that the company is not generating sufficient cash to sustain operations or fund growth. The capital expenditure of -369,213,145,110.0 VND indicates significant investment in infrastructure, but this has not translated into positive cash flow. The company faces medium liquidity risk and low dilution risk, but the key flag of negative net cash after subtracting total debt is a significant concern. The company has not issued new shares recently, and there is no indication of dilution pressure in the near term. Recent filings and transcripts do not provide additional insights into the company's operations or strategic direction. The company's financial performance remains a concern, with no clear path to profitability or improved cash flow.
Key takeaways
  • TNH Hospital Group JSC is operating at a significant loss, with negative operating and net income.
  • The company's liquidity position is weak, with a current ratio below 1 and negative free cash flow.
  • The company's profitability metrics are poor, with negative return on equity and return on assets.
  • The company's operations are entirely concentrated in Vietnam, with no geographic diversification.
  • The company is investing heavily in capital expenditures but is not generating positive cash flow.
  • # RATIONALES
  • margin_outlook_rationale: The company's operating margin is negative, indicating a lack of cost control and pricing power.
  • rd_outlook_rationale: There is no specific information on R&D spending, but the company's focus is on hospital operations rather than pharmaceutical R&D.
Financial snapshot
PeriodHA-latest
CurrencyVND
Revenue$509.54B
Gross profit$27.95B
Operating income-$90.15B
Net income-$93.13B
R&D
SG&A
D&A
SBC
Operating cash flow-$47.91B
CapEx-$369.21B
Free cash flow-$389.89B
Total assets$2.87T
Total liabilities$1.17T
Total equity$1.71T
Cash & equivalents
Long-term debt$1.04T
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.71T
Net cash-$1.04T
Current ratio0.9
Debt/Equity0.6
ROA-3.2%
ROE-5.5%
Cash conversion51.0%
CapEx/Revenue-72.5%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Pharmaceuticals · cohort 25 companies
MetricTNHActivity
Op margin-17.7%18.2% medp25 18.2% · p75 24.6%bottom quartile
Net margin-18.3%14.7% medp25 11.7% · p75 28.1%bottom quartile
Gross margin5.5%19.7% medp25 19.7% · p75 39.8%bottom quartile
R&D / revenue24.3% medp25 6.6% · p75 24.3%
CapEx / revenue-72.5%4.9% medp25 4.2% · p75 6.3%bottom quartile
Debt / equity61.0%71.3% medp25 19.0% · p75 91.7%below median
Observations
IR observations
Mean price target12,065.22 VND
Median price target12,065.22 VND
High price target13,130.43 VND
Low price target11,000.00 VND
Mean recommendation4.00 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count0.00
Hold count0.00
Sell count2.00
Strong-sell count0.00
Mean EPS estimate14.30 VND
Last actual EPS-638.00 VND
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 05:10 UTC#3a1e2cdb
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 05:12 UTCJob: 81ca047d